Dapoxetine

Spécifications

119356-77-3Numéro CAS

(1S)-N,N-dimethyl-3-naphthalen-1-yloxy-1-phenylpropan-1-amineNom IUPAC

C21H23NOFormule chimique

305.4 g/molMasse molaire

Dapoxetine; 119356-77-3; Dapoxetina; Dapoxetinum; Kutub; LY-210448; DTXSID0057627; LY 210448; GB2433A4M3; DTXCID1031416; dimethyl[(1S)-3-(naphthalen-1-yloxy)-1-phenylpropyl]amine; Benzenemethanamine, N,N-dimethyl-alpha-(2-(1-naphthalenyloxy)ethyl)-, (+)-; dimethyl((1S)-3-(naphthalen-1-yloxy)-1-phenylpropyl)amine; RefChem:130954; G04BX14; LY21044; (S)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine; Dapoxetine [INN]; MFCD00865355; (1S)-N,N-dimethyl-3-naphthalen-1-yloxy-1-phenylpropan-1-amine; LY210448; C21H23NO; Benzenemethanamine, N,N-dimethyl-alpha-[2-(1-naphthalenyloxy)ethyl]-, (alphaS)-; Dapoxetin; Dapoxetinum [INN-Latin]; Dapoxetina [INN-Spanish]; Dapoxetine (Free Base); UNII-GB2433A4M3; S-(+)-N,N-Dimethyl-a-[2-(naphthalenyloxy)ethyl]benzenemethanamine; (alphaS)-N,N-Dimethyl-alpha-[2-(1-naphthalenyloxy)ethyl]benzenemethanamine;(S)-(+)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine;(S)-(+)-N,N-Dimethyl-alpha-[2-(1-naphthalenyloxy)ethyl]benzenemethanamine; DAPOXETINE [MI]; Dapoxetine Impurity 102; DAPOXETINE [MART.]; DAPOXETINE [WHO-DD]; SCHEMBL34479; GTPL7901; orb1226837; orb1710762; CHEMBL2110900; SCHEMBL29387056; CHEBI:135962; USRHYDPUVLEVMC-FQEVSTJZSA-N; GLXC-07957; (1S)-N,N-dimethyl-3-(1-naphthyloxy)-1-phenyl-propan-1-amine; EX-A4045; HY-B0304; Tox21_113784; AKOS015895183; DB04884; NCGC00253658-01; NCGC00253658-02; NCGC00253658-07; NCGC00253658-09; AC-22603; AS-72866; CAS-119356-77-3; NS00010178; AB01274725-01; AB01274725_02; F233998; Q424965; BRD-K51579475-003-02-4; (+)-(S)-N,N-DIMETHYL-.ALPHA.-(2-(1-NAPHTHYLOXY)ETHYL)BENZYLAMINE; (1S)-N,N-Dimethyl-3-[(naphthalen-1-yl)oxy]-1-phenylpropan-1-amine; Benzenemethanamine, N,N-dimethyl-|A-[2-(1-naphthalenyloxy)ethyl]-, (|AS)-; BENZENEMETHANAMINE, N,N-DIMETHYL-.ALPHA.-(2-(1-NAPHTHALENYLOXY)ETHYL)-Synonymes